Cargando…

Late gadolinium enhancement characteristics in giant cell myocarditis

AIMS: This study aims to demonstrate the characteristics of late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance (CMR) imaging in patients with giant cell myocarditis (GCM). METHODS AND RESULTS: Six patients histologically diagnosed with GCM were retrospectively recruited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shujuan, Chen, Xiuyu, Li, Jinghui, Sun, Yang, Song, Jialin, Wang, Hongyue, Zhao, Shihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120362/ https://www.ncbi.nlm.nih.gov/pubmed/33655686 http://dx.doi.org/10.1002/ehf2.13276

Ejemplares similares

Correlation of Myocardial Strain and Late Gadolinium Enhancement by Cardiac Magnetic Resonance After a First Anterior ST-Segment Elevation Myocardial Infarction
por: Yu, Shiqin, et al.
Publicado: (2021)

Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
por: Hu, Yuxiao, et al.
Publicado: (2021)

Association between ECG parameters and late gadolinium enhancement along the course of myocarditis
por: Károlyi, Mihály, et al.
Publicado: (2023)

Association of QRS-T angle and Late Gadolinium Enhancement in patients with a Clinical Suspicion of Myocarditis
por: Jensen, C.J., et al.
Publicado: (2021)

Comparison of cardiovascular magnetic resonance characteristics and clinical consequences in children and adolescents with isolated left ventricular non-compaction with and without late gadolinium enhancement
por: Cheng, Huaibing, et al.
Publicado: (2015)

Prognostic significance of regional edema and quantitative assessment of late gadolinium enhancement in patients with acute myocarditis
por: Vermes, Emmanuelle, et al.
Publicado: (2011)

Early Left Ventricular Involvement Detected by Cardiovascular Magnetic Resonance Feature Tracking in Arrhythmogenic Right Ventricular Cardiomyopathy: The Effects of Left Ventricular Late Gadolinium Enhancement and Right Ventricular Dysfunction
por: Chen, Xiuyu, et al.
Publicado: (2019)

Quantitative Assessment of Late Gadolinium Enhancement and Edema at Cardiac Magnetic Resonance in Low-Risk Myocarditis Patients
por: Monti, Caterina Beatrice, et al.
Publicado: (2022)

Myocarditis and heart function impairment occur in neonatal mice following in utero exposure to the Zika virus
por: Bai, Chongzhi, et al.
Publicado: (2021)

The Effect of Fingolimod on Conversion of Acute Gadolinium‐Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis
por: Oommen, Vinit V., et al.
Publicado: (2015)

Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate
por: Gallegos, Cesia, et al.
Publicado: (2019)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Comparison of 3D and 2D late gadolinium enhancement magnetic resonance imaging in patients with acute and chronic myocarditis
por: Polacin, M., et al.
Publicado: (2020)

Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease
por: Jones, Richard E., et al.
Publicado: (2023)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Comparison of the amount of affected myocardium quantified by late gadolinium enhancement and the degree of myocardial necrosis measured by cardiac troponin T in patients with myocarditis
por: Andre, Florian, et al.
Publicado: (2013)

Association of ECG parameters with late gadolinium enhancement and outcome in patients with clinical suspicion of acute or subacute myocarditis referred for CMR imaging
por: Fischer, Kady, et al.
Publicado: (2020)

The pattern of late gadolinium enhancement by cardiac MRI in fulminant myocarditis and its prognostic implication: a two-year follow-up study
por: Jiang, Luying, et al.
Publicado: (2023)

Myocarditis after RNA-based vaccines for coronavirus.
por: Cordero, Alberto, et al.
Publicado: (2022)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

Varied distributions of late gadolinium enhancement found among patients meeting cardiovascular magnetic resonance criteria for isolated left ventricular non-compaction
por: Wan, Junyi, et al.
Publicado: (2013)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
por: Doltra, Adelina, et al.
Publicado: (2013)

Late Gadolinium Enhancement after COVID-19 Vaccination
por: Wilson, Hunter, et al.
Publicado: (2021)

Role of Late Gadolinium Enhancement in the Assessment of Myocardial Viability
por: Shah, Dr. Viraj, et al.
Publicado: (2022)

Cardiac phase-resolved late gadolinium enhancement imaging
por: Weingärtner, Sebastian, et al.
Publicado: (2022)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Myocarditis following COVID-19 mRNA vaccination
por: Abu Mouch, Saif, et al.
Publicado: (2021)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis
por: Sano, Makoto, et al.
Publicado: (2014)

Myocarditis following COVID-19 vaccination – A case series
por: Levin, Dan, et al.
Publicado: (2021)

Case Report: Disappearance of Late Gadolinium Enhancement and Full Functional Recovery in a Young Patient With SARS-CoV-2 Vaccine-Related Myocarditis
por: Korosoglou, Grigorios, et al.
Publicado: (2022)

A case of coronavirus disease 2019 vaccine‐related myocarditis with late gadolinium enhancement on cardiac magnetic resonance imaging persisting over acute phase
por: Konno, Ai, et al.
Publicado: (2022)

A humanized HLA-DR4 mouse model for autoimmune myocarditis
por: Şelli, M. Emrah, et al.
Publicado: (2017)

Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis
por: Hadley, Stephanie M., et al.
Publicado: (2022)

Respiratory bellows-gated left atrial late gadolinium enhancement
por: Peters, Dana C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i84isndck9mbj6jn73dajbq2hc